| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/15/2009 | CN101480374A Stable solid pharmaceutical composition |
| 07/15/2009 | CN100513417C Aqueous suspensions of ciclesonide for nebulisation |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100512944C Method of growing crystals |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |
| 07/15/2009 | CN100512876C Coated metal pyrithione particles for treatment of microorganisms |
| 07/15/2009 | CN100512841C Medication for treating bronchitis |
| 07/15/2009 | CN100512837C Plaster for treating osteoarthropathy and preparing method |
| 07/15/2009 | CN100512833C Medication for treating cough |
| 07/15/2009 | CN100512832C Medication for treating ache |
| 07/15/2009 | CN100512825C Icy seven drop pills and its preparation method |
| 07/15/2009 | CN100512824C Medication for treating headache |
| 07/15/2009 | CN100512815C Matrine enteric coatel tablet and its preparation method |
| 07/15/2009 | CN100512813C Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512810C Premixed amiodarone parenteral solution and method for making the same |
| 07/15/2009 | CN100512807C Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 07/15/2009 | CN100512806C Therapeutic patch with polysiloxane matrix comprising capsaicin |
| 07/15/2009 | CN100512804C Preparing process of botanical hollow enteric hard capsule |
| 07/15/2009 | CN100512803C Natural carotene soft capsule and its production method |
| 07/15/2009 | CN100512802C Sustained release tablet of calcium dobesilate and preparation process thereof |
| 07/15/2009 | CN100512801C Compound isatis root effervescent tablet and its preparation method |
| 07/15/2009 | CN100512800C Orally disintegrating tablet for treating cerebral apoplexy and preparation process thereof |
| 07/15/2009 | CN100512799C Effervescence tablet containing multiplex vitamin including iron, zinc and calcium, ring shaped preparation and preparation method |
| 07/15/2009 | CN100512798C Method for preparing submicron particle suspensions |
| 07/15/2009 | CN100512797C Oral solid vatility source preparation and its preparing process |
| 07/15/2009 | CN100512796C Medicinal composition containing scutellaria glucoside and bupleurum and its preparation method |
| 07/14/2009 | US7560490 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 07/14/2009 | US7560486 An isotonic lipid emulsion free of vegetable oils:(i) 78 to 95% by weight of medium chain triglycerides (MCT), (ii) 5 to 22% by weight of fish oil; to increase the amount of omega-3 fatty acids of cell membranes of organs and tissues |
| 07/14/2009 | US7560444 Formulations comprising low molecular weight heparin and a therapeutic, prophylactic or diagnostic agent; improved bioavailability; side effect reduction |
| 07/14/2009 | US7560429 Bioavailability; freeze-dried packages |
| 07/14/2009 | US7560160 Multifunctional particulate material, fluid, and composition |
| 07/14/2009 | US7560122 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 07/14/2009 | US7560121 fluphenazine dihydrochloride-containing transdermal therapeutic system (TTS) which releases at least desired active agent to the human skin, comprises an enhancer and has a skin-facing pressure-sensitive adhesive layer based on polymers which are pure hydrocarbons; treating schizophrenia and psychoses |
| 07/14/2009 | US7560120 Using citric acid esters or ethers |
| 07/14/2009 | US7560114 Administering a polysaccharide or glycopeptide component having terminal fucose residues with alpha 1,2-fucosidic linkages; increasing hematopoietic activity |
| 07/14/2009 | US7560098 Compounds derived from polyanhydride resins with film-forming, UV-absorbing, and photostabilizing properties, compositions containing same, and methods of using the same |
| 07/14/2009 | US7559926 Actuation system and method for an implantable infusion pump |
| 07/14/2009 | US7559494 Method of forming non-stoichiometric nanoscale powder comprising temperature-processing of a stoichiometric metal compound |
| 07/14/2009 | CA2487834C Orally disintegrating tablets and process for obtaining them |
| 07/14/2009 | CA2472392C Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 07/14/2009 | CA2439222C Identification of partial agonists of the a2a adenosine receptor |
| 07/14/2009 | CA2409610C Inhalation therapy decongestant with foraminous carrier |
| 07/14/2009 | CA2402988C Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 07/14/2009 | CA2390933C Oral solid preparation comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide |
| 07/14/2009 | CA2390092C Solid dispersion pharmaceutical formulations |
| 07/14/2009 | CA2386790C Chromium-histidine complexes as nutrient supplements |
| 07/14/2009 | CA2366754C Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 07/14/2009 | CA2306560C Topical antifungal composition |
| 07/14/2009 | CA2254548C Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections |
| 07/14/2009 | CA2183543C Sexual steroid-containing transdermal therapeutic systems |
| 07/12/2009 | CA2712010A1 Solid pharmaceutical dosage form |
| 07/11/2009 | CA2639285A1 Solid dosage formulations containing weight-loss drugs |
| 07/09/2009 | WO2009086558A1 Improved compositions and methods for the delivery of nucleic acids |
| 07/09/2009 | WO2009086483A2 Biocompatible protein particles, devices and methods thereof |
| 07/09/2009 | WO2009086296A2 Counter-pressure filtration of proteins |
| 07/09/2009 | WO2009086166A1 Room temperature stable, lyophilized natriuretic peptide formulations |
| 07/09/2009 | WO2009086112A2 Apparatus and methods for delivering therapeutic agents |
| 07/09/2009 | WO2009086108A1 Stable elsamitrucin salt formulations |
| 07/09/2009 | WO2009086098A1 Porous microparticles for injection and processes for forming the same |
| 07/09/2009 | WO2009086097A1 Intraocular irrigating solutions comprising histidine and methods for treating corneal edema |
| 07/09/2009 | WO2009086076A2 Particles for injection and processes for forming the same |
| 07/09/2009 | WO2009086073A1 Stabilized glycerophosphate-containing surgical irrigating solution |
| 07/09/2009 | WO2009086067A2 Particles for injection and processes fo forming the same |
| 07/09/2009 | WO2009086055A1 Enhancing photostabilization of oxymetazoline |
| 07/09/2009 | WO2009086046A1 Orally disintegrating tablet compositions of temazepam |
| 07/09/2009 | WO2009085952A1 Process for preparing microparticles having a low residual solvent volume |
| 07/09/2009 | WO2009085889A2 Compositions and methods for reducing or preventing water loss from the skin |
| 07/09/2009 | WO2009085832A2 Manufacture of tablet |
| 07/09/2009 | WO2009085778A1 Pharmaceutical composition |
| 07/09/2009 | WO2009085766A2 Fenofibric acid amorphous dispersion; method of making; and method of use thereof |
| 07/09/2009 | WO2009085310A1 Extended-release pharmaceutical compositions containing zolpidem |
| 07/09/2009 | WO2009085302A2 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin |
| 07/09/2009 | WO2009085180A1 Treatment of sepsis and inhibition of mif by d-t4 |
| 07/09/2009 | WO2009084975A1 Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| 07/09/2009 | WO2009084801A1 Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same |
| 07/09/2009 | WO2009084678A1 Oral cavity disintegrating tablet and method of producing the same |
| 07/09/2009 | WO2009084659A1 Solution preparation containing antibody at high concentration |
| 07/09/2009 | WO2009084611A1 Antipruritic sheet |
| 07/09/2009 | WO2009084494A1 Antimicrobial agent for gram-positive bacteria |
| 07/09/2009 | WO2009084234A1 Sheet preparation to be applied to the human body |
| 07/09/2009 | WO2009084216A1 Oral powder and granular antitumor agent |
| 07/09/2009 | WO2009084044A1 Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan |
| 07/09/2009 | WO2009084041A2 Pharmaceutical compositions of dexibuprofen |
| 07/09/2009 | WO2009084040A1 Once a day formulation of angiotensin receptor blockers |
| 07/09/2009 | WO2009084036A2 Composition for treatment of viral infections |
| 07/09/2009 | WO2009084017A2 Taste-masked orally disintegrating tablets of memantine hydrochloride |
| 07/09/2009 | WO2009084003A1 Pharmaceutical compositions of amlodipine and valsartan |
| 07/09/2009 | WO2009083972A2 Compositions and methods for enhancing the activity of podophyllotoxin |
| 07/09/2009 | WO2009083759A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | WO2009083686A1 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |
| 07/09/2009 | WO2009083664A1 Novel taxoid-based compositions |
| 07/09/2009 | WO2009083607A1 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
| 07/09/2009 | WO2009083561A1 A slow-release formulation based on an association of glycogen and alginate |
| 07/09/2009 | WO2009082883A1 Antiobesity composition |
| 07/09/2009 | WO2009082817A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | WO2009082793A1 Evanescent cream comprising plant oils and process for producing the same |
| 07/09/2009 | WO2009066955A3 Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same |
| 07/09/2009 | WO2009066138A3 Stabilization of vitamin b complex and lidocaine hydrochloride injection |
| 07/09/2009 | WO2009052942A3 Stabilization of hydrophobic protein therapeutic agents |